TheraVet SA (ALVET.PA)
EUR 0.11
(-0.46%)
EUR 0.11
(-0.46%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 123.34 Thousand EUR | 35.52% |
| 2022 | 91.01 Thousand EUR | -53.88% |
| 2021 | 197.33 Thousand EUR | 215.12% |
| 2020 | -171.41 Thousand EUR | -74529730.44% |
| 2019 | -0.23 EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 130.87 Thousand EUR | 6.11% |
| 2024 Q2 | 130.87 Thousand EUR | 0.0% |
| 2023 Q4 | 123.34 Thousand EUR | 0.0% |
| 2023 Q2 | 123.44 Thousand EUR | 0.0% |
| 2023 Q1 | 123.44 Thousand EUR | 35.63% |
| 2023 FY | 123.34 Thousand EUR | 35.52% |
| 2023 Q3 | 123.34 Thousand EUR | -0.08% |
| 2022 Q1 | 252.48 Thousand EUR | 27.95% |
| 2022 Q4 | 91.01 Thousand EUR | 0.0% |
| 2022 Q3 | 91.01 Thousand EUR | -63.95% |
| 2022 Q2 | 252.48 Thousand EUR | 0.0% |
| 2022 FY | 91.01 Thousand EUR | -53.88% |
| 2021 Q4 | 197.33 Thousand EUR | 0.0% |
| 2021 Q1 | 41.7 Thousand EUR | 124.33% |
| 2021 Q2 | 41.7 Thousand EUR | 0.0% |
| 2021 Q3 | 197.32 Thousand EUR | 373.15% |
| 2021 FY | 197.33 Thousand EUR | 215.12% |
| 2020 Q1 | - EUR | 0.0% |
| 2020 FY | -171.41 Thousand EUR | -74529730.44% |
| 2020 Q3 | - EUR | 0.0% |
| 2020 Q4 | -171.41 Thousand EUR | 0.0% |
| 2020 Q2 | - EUR | 0.0% |
| 2019 FY | -0.23 EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | 44.189% |
| ABIVAX Société Anonyme | 1.00 EUR | -12334100.0% |
| Adocia SA | 272 Thousand EUR | 54.654% |
| Aelis Farma SA | 53 Thousand EUR | -132.721% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 92.915% |
| genOway Société anonyme | 982.75 Thousand EUR | 87.449% |
| IntegraGen SA | 311.44 Thousand EUR | 60.397% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | 25.076% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 111.125% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 89.928% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 203.496% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | -35.541% |
| Valbiotis SA | 1 Million EUR | 87.727% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -12334100.0% |
| argenx SE | 281.12 Million EUR | 99.956% |
| BioSenic S.A. | - EUR | -Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 90.211% |
| DBV Technologies S.A. | 1.00 USD | -12334100.0% |
| Galapagos NV | 73.97 Million EUR | 99.833% |
| Genfit S.A. | 4000.00 EUR | -2983.55% |
| GeNeuro SA | - EUR | -Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | -12334100.0% |
| Innate Pharma S.A. | 1.00 EUR | -12334100.0% |
| Inventiva S.A. | 417 Thousand EUR | 70.422% |
| MaaT Pharma SA | 190 Thousand EUR | 35.083% |
| MedinCell S.A. | -6.71 Million EUR | 101.837% |
| Nanobiotix S.A. | 200 Thousand EUR | 38.329% |
| Onward Medical N.V. | 936 Thousand EUR | 86.822% |
| Oryzon Genomics S.A. | 6029.00 EUR | -1945.812% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Oxurion NV | 128 Thousand EUR | 3.639% |
| Pharming Group N.V. | 51.38 Million EUR | 99.76% |
| Poxel S.A. | 2.95 Million EUR | 95.827% |
| GenSight Biologics S.A. | 1.00 EUR | -12334100.0% |
| Transgene SA | - EUR | -Infinity% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 1.03 Billion EUR | 99.988% |
| Valneva SE | 44.46 Million EUR | 99.723% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -12334100.0% |